Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: A survival analysis

Cancer

Volumn 117, Issue 18, 2011, Pages 4277-4285

  Sun, Maxine ^a   Abdollah, Firas ^a,b   Liberman, Daniel ^a   Abdo, Al'A ^a   Thuret, Rodolphe ^a,c   Tian, Zhe ^a   Shariat, Shahrokh F ^d   Montorsi, Francesco ^b   Perrotte, Paul ^c   Karakiewicz, Pierre I ^a,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIV MONTPELLIER   (France)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

disparities; oncologic outcome; race; socioeconomic status; testicular cancer

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; DEATH; GERM CELL TUMOR; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; PELVIS LYMPH NODE; PREDICTION; PRIORITY JOURNAL; RACE; RACE DIFFERENCE; RESIDENTIAL AREA; SEMINOMA; SOCIAL STATUS; TESTIS NONSEMINOMA CANCER;

ADULT; AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; MALE; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; SEER PROGRAM; SOCIAL CLASS; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS;

EID: 80052506545     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25969     Document Type: Article

References (37)

1. Chavez-Macgregor M, Litton J, Chen H, et al. Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity. Cancer. 2010; 116: 4168-4177.
2. Du XL, Liu C-C,. Racial/ethnic disparities in socioeconomic status, diagnosis, treatment and survival among Medicare-insured men and women with head and neck cancer. J Health Care Poor Underserved. 2010; 21: 913-930.
3. Fedewa SA, Ward EM, Stewart AK, et al. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African-American and Hispanic populations: a national cohort study 2004-2006. J Clin Oncol. 2010; 28: 4135-4141.
4. Hollenbeck BK, Dunn RL, Ye Z, et al. Racial differences in treatment and outcomes among patients with early stage bladder cancer. Cancer. 2010; 116: 50-56.
5. Scosyrev E, Noyes K, Feng C, et al. Sex and racial differences in bladder cancer presentation and mortality in the United States. Cancer. 2009; 115: 68-74.
6. Vicini F, Jones P, Rivers A, et al. Differences in disease presentation, management techniques, treatment outcome, and toxicities in African-American women with early stage breast cancer treated with breast-conserving therapy. Cancer. 2010; 116: 3485-3492.
7. Shavers V, Brown M,. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94: 334-357. (Pubitemid 34257478)
8. Albain KS, Unger JM, Crowley JJ, et al. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009; 101: 984-992.
9. Artinyan A, Mailey B, Sanchez-Luege N, et al. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer. 2010; 116: 1367-1377.
10. Pettaway C,. Racial differences in the androgen/androgen receptor pathway in prostate cancer. J Natl Cancer Inst. 1999; 91: 653-660.
11. Bach P, Cramer L, Warrent J, et al. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999; 341: 1198-1205. (Pubitemid 29480659)
12. Biggs ML, Schwartz SM,. Differences in testis cancer survival by race and ethnicity: a population-based study, 1973-1999 (United States). Cancer Causes Control. 2004; 15: 437-444. (Pubitemid 39060935)
13. Bridges P, Sharifi R, Razzaq A, et al. Decreased survival of black Americans with testicular cancer. J Urol. 1998; 159: 1221-1223. (Pubitemid 28172800)
14. Gajendran V, Nguyen M, Ellison L,. Testicular cancer patterns in African-American men. Urology. 2005; 66: 602-605. (Pubitemid 41244807)
15. Moul J, Schanne F, Thompson I, et al. Testicular cancer in blacks. Cancer. 1993; 73: 388-393.
16. Hoffman KE, Chen M-H, Punglia RS, et al. Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma. J Clin Oncol. 2008; 26: 3937-3942.
17. Nattinger AB, McAuliffe TL, Schapira MM,. Generalizability of the Surveillance, Epidemiology, and End Results registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol. 1997; 50: 939-945. (Pubitemid 27423524)
18. National Cancer Institute; Surveillance, Epidemiology, and End Results (SEER) Program. About the SEER Program. Bethesda, MD: National Cancer Institute; 2010. Accessed September 2010.
19. Bach P, Guadagnoli E, Schrag D, et al. Patient demographic and socioeconomic characteristics in the SEER-Medicare database: applications and limitations. Med Care. 2002; 40: IV19-IV25.
20. US Census Bureau. Census 2000. Washington, DC: US Census Bureau; 2000.
21. McGlynn KA, Devesa SS, Graubard BI, et al. Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol. 2005; 23: 5757-5761.
22. Du XL, Fang S, Coker AL, et al. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 2006; 106: 1276-1285. (Pubitemid 43363904)
23. Robert SA, Strombom I, Trentham-Dietz A, et al. Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects. Epidemiology. 2004; 15: 442-450. (Pubitemid 40416932)
24. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009; 59: 225-249.
25. McGlynn KA, Devesa S, Sigurdon A, et al. Trends in the incidence of testicular germ cell tumors in the United States. Cancer. 2003; 97: 63-70. (Pubitemid 36033864)
26. Holmes L, Escalante C, Garrison O, et al. Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting racial paradigm? Public Health. 2008; 122: 862-872.
27. Kaufman J, Cooper R, McGee D,. Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology. 1997; 8: 621-628. (Pubitemid 27449492)
28. Mackenbach J, Stirbu I, Roskam A, et al. Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008; 358: 2468-2483.
29. Bach P, Schrag D, Brawley O, et al. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002; 287: 2106-2113. (Pubitemid 34437345)
30. Klein JB, Nguyen CT, Saffore L, et al. Racial disparities in urologic health care. J Natl Med Assoc. 2010; 102: 108-117.
31. Shwartz M,. Estimates of lead time and length bias in a breast cancer screening program. Cancer. 1980; 46: 844-851. (Pubitemid 10034469)
32. Feinstein A, Sosin D, Wells C,. The Will Rogers Phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985; 312: 1604-1608. (Pubitemid 15062653)
33. Marcella S, Miller J,. Racial differences in colorectal cancer mortality: the importance of stage and socioeconomic status. J Clin Epidemiol. 2001; 54: 359-366. (Pubitemid 32303459)
34. Ragland K, Selvin S, Merrill D,. Black-white differences in stage-specific cancer survival: analysis of 7 selected sites. Am J Epidemiol. 1991; 133: 672-682.
35. Steinhorn S, Myers M, Hankey B, et al. Factors associated with survival differences between black women and white women with cancer of the uterine corpus. Am J Epidemiol. 1986; 124: 85-93. (Pubitemid 16095838)
36. Albers P, Siener R, Krege S, et al. Randomized phase III trial comparing retroperitoneal lymph node dissection with 1 course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. J Clin Oncol. 2008; 26: 2966-2972.
37. Nguyen CT, Fu AZ, Gilligan TD, et al. Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis. J Clin Oncol. 2010; 28: 119-125.